Skip to main content

Clinical trials report

Current Atherosclerosis Reports volume 6, pages 333–334 (2004)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Toth PP: Clinician update: HDL and cardiovascular risk. Circulation 2004, 109: 1809–1812.

    PubMed  Article  Google Scholar 

  2. Gotto AM, Brinton EA: Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease. A working group report and update. J Am Coll Cardiol 2004, 43: 717–724.

    PubMed  Article  CAS  Google Scholar 

  3. Toth PP: Reverse cholesterol transport: high-density lipoprotein’s magnificent mile. Curr Atheroscler Rep 2003, 5: 386–393.

    PubMed  Google Scholar 

  4. Nofer J, Kegrel B, Fobker M, et al.: HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 2002, 161: 1–16.

    PubMed  Article  CAS  Google Scholar 

  5. Toth PP, Davidson MH: Therapeutic interventions targeted at the augmentation of reverse cholesterol transport. Curr Opin Cardiol 2004, 19: 374–379.

    PubMed  Article  Google Scholar 

  6. Robins SJ, Collins D, Wittes JT, et al.: VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial. Relation of gemfibrozil treatment and lipid levels with major coronary events. JAMA 2001, 285: 1586–1589.

    Article  Google Scholar 

  7. Downs JR, Clearfield M, Weis S, et al.: Primary prevention of acute coronary events with Lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS. JAMA 1998, 279: 1615–1622.

    PubMed  Article  CAS  Google Scholar 

  8. Assman G: Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management. Am J Cardiol 2000, 87(suppl): 2B-7B.

    Google Scholar 

  9. Miyazak A, Sakuma S, Morikawa W, et al.: Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits. Arterioslcer Thromb Vasc Biol 1995, 15: 1882–1888.

    Google Scholar 

  10. Tangirala RK, Tsukamoto K, Chun SH, et al.: Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 1999, 100: 1816–1822.

    PubMed  CAS  Google Scholar 

  11. Weisgraber KH, Rall SC, Bersot TP, et al.: Apolipoprotein A-I Milano: detection of normal A-I in affected subjects and evidence for cysteine to arginine substitution in the variant A-I. J Biol Chem 1983, 258: 2508–2513.

    PubMed  CAS  Google Scholar 

  12. Chiesa G, Sirtori CR: Apolipoprotein A-I Milano: current perspectives. Curr Opin Lipidol 2003, 14: 159–163.

    PubMed  Article  CAS  Google Scholar 

  13. Chisea G, Monteggia E, Marchesi M, et al.: Recombinant apolipoprotein A-I Milano infusion into rabbit carotid artery rapidly removes lipid from fatty streaks. Circ Res 2002, 90: 974–980.

    Article  Google Scholar 

  14. Shah PK, Yano J, Reyes O, et al.: High-dose recombinant apolipoprotein A-I Milano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice: potential implications for acute plaque stabilization. Circulation 2001, 103: 3047–3050.

    PubMed  CAS  Google Scholar 

  15. Navab M, Anantharamaiah GM, Hama S, et al.: Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 2002, 105: 290–292.

    PubMed  Article  CAS  Google Scholar 

Download references

Authors
  1. Peter P. Toth MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Toth, P.P. Clinical trials report. Curr Atheroscler Rep 6, 333–334 (2004). https://doi.org/10.1007/s11883-004-0042-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-004-0042-5

Keywords

  • Reverse Cholesterol Transport
  • Plaque Volume
  • Atheromatous Plaque
  • Acute Coronary Event
  • Cholesterol Ester Transfer Protein